Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Longevity Research Boosted by Alamar Biosciences Deal
Human Longevity, Inc. (HLI), a well-known leader in precision health and longevity-centered care, has announced a new partnership with Alamar Biosciences, a company that specializes in precision proteomics. This collaboration is set to introduce new proteomic testing services that will increase scientific understanding of human aging and improve early detection of diseases.
Piedmont Atlanta Hospital Completes First Rare Liver-Heart Transplant
Piedmont Atlanta Hospital recently completed a rare combined liver and heart transplant, which is the first of its kind in Georgia in ten years and only the second adult dual transplant in the state. According to the United Network for Organ Sharing, fewer than 50 liver-heart transplants have been done in the southeastern U.S., showing how complex and uncommon this surgery is. Piedmont Atlanta is one of the busiest transplant centers in the country, ranking among the top ten for liver transplants and the top five for heart transplants based on the number of patients they treat.
Esaote and Epica Partner to Expand MRI and CT Imaging Reach
Esaote North America, a leading provider of MRI, ultrasound, and healthcare IT solutions, has partnered with Epica International, a global leader in advanced CT and imaging technologies. This collaboration combines the strengths of both companies to enhance their presence and accelerate the adoption of cutting-edge MRI and CT imaging solutions across human and veterinary healthcare markets.
Brightonix PHAROS PET Imaging Gets FDA Clearance
Brightonix Imaging, a company known worldwide for its progress in medical imaging, has announced that its PHAROS PET Scanner has been officially approved by the U.S. Food and Drug Administration. This important approval means the company can now start selling the scanner in the United States. It also marks a big step forward for nuclear imaging technology, offering doctors better tools for finding and diagnosing diseases early on.
Virax Biolabs Partners with Emory University on ViraxImmune Clinical Studies
Virax Biolabs Group Limited, a biotechnology company focused on diagnosing immune responses, has entered a research agreement with Emory University to advance clinical studies for its ViraxImmune platform. The collaboration involves Emory’s Center for the Advancement of Diagnostics for a Just Society (ADJUST Center) and will investigate immune profiles in individuals with long COVID, medically referred to as post-acute sequelae of SARS-CoV-2 (PASC). These studies are intended to support the regulatory progress of ViraxImmune, which is designed to deliver more detailed insights into immune system activity, particularly in chronic health conditions that conventional diagnostic tools may not fully capture.
To share your insights, please write to us at sudipto@intentamplify.com
